Phase Advance executives Dr. Tawanda Gumbo and Rachael Sparks will be attending the 2026 JP Morgan Healthcare Conference January 12-15, 2026 in San Francisco, California. Look out for us at the conference, or reach out here to pre-arrange meeting times.
In a competition against 8 startups chosen from hundreds of applicants, a three-judge panel representing expertise from Labcorp Venture Fund, Merck Global Health Innovation Fund, and Flare Capital Partners, Phase Advance was awarded the HLTH USA 2025 Pitch Competition’s Top Life Sciences Startup, in Vegas, NV, on Oct 21.
Phase Advance Cofounder Rachael Sparks will compete in the HLTH USA 2025 Pitch Competition, in Vegas, NV, on Oct 21. We’re honored to have been selected from hundreds of applicants to present our technology before HLTH USA’s ~15,000 attendees.
Phase Advance Cofounder Dr. Tawanda Gumbo to speak at ACoP 2024, Nov 10 – 13th, on “AI-aided Virtual Disease Progression Clinical Trials – The marriage of nonlinear mathematical modeling, biology, and AI in predicting future individual patient responses in global health”. Learn More.
OCTOBER 16, 2025
Predictive AI modeling startup Phase Advance and biotech-focused venture fund QNova Capital unite to accelerate next generation therapeutics and reshape the FDA regulatory path.
APRIL 10, 2025
FDA Announces Phase-Out of Animal Models and Incentives for Use of New Emerging Methodologies (NAMs) in Preclinical Studies for Monoclonal Antibodies. Read the Post.
MARCH 25, 2024
Phase Advance Technology Powers In Silico Clinical Trial of Common Antibiotic for Life-Threatening Lung Disease. Read Press Release.
